Abstract:Upconversion photodynamic therapy (PDT), utilizing upconversion nanoparticles (UCNPs) to excite surface-anchored molecular photosensitizers, enables to treat deep-seated tumors using tissue-penetrating near-infrared (NIR) light. Yet, this technique was substantially limited by the O 2 deficiency in solid tumors and the inability to visualize reactive oxygen species (ROS) for precise treatment. To address this challenge, we devised a neotype of multifunctional upconversion photosensitizer which not only efficiently generates hydroxyl radical (•OH) to induce cell apoptosis in hypoxic tumor, but also dynamically shows accumulated amount of radical •OH in situ in tumor. This photosensitizer consists of NaYbF 4 : 4 upconversion nanoparticles (UCNPs) as the core, and mesoporous silica as the shell which was loaded with heterojunction Ag 0 -Ag 2 S quantum dots and IR 820 molecular probe on the surface. Under 980 nm NIR excitation, thulium ultraviolet and blue upconversion luminescence (UCL) excite spectrally overlapped Ag 0 -Ag 2 S, with metal-semiconductor heterojunction for enhanced electron-hole separation, to produce highly toxic •OH to induce cell death. While produced •OH can specifically degrade surface IR 820 dyes to remove luminescence resonant energy transfer from UCNPs to IR 820 dyes, this can turn on quenched UCL entailing dynamical observation of in situ generated •OH. Intravenous injection of the photosensitizers resulted in 8-fold tumor volume reduction as compared to control group, while dynamically showing accumulated production of •OH in hypoxic 4T1 tumor-bearing mice (Balb/c). These findings untap the use of upconversion photosensitizer for precise and visualized treatment of deep-seated hypoxic tumors in live mammals.

Ultraviolet phototoxicity of upconversion nanoparticles illuminated with near-infrared light

Near-infrared light induced in vivo photodynamic therapy of cancer based on upconversion nanoparticles

Upconversion Nanoparticles for Photodynamic Therapy and Other Cancer Therapeutics

Near infrared light activated upconversion nanoparticles (UCNP) based photodynamic therapy of prostate cancers: An in vitro study

Red-emitting upconverting nanoparticles for photodynamic therapy in cancer cells under near-infrared excitation.

Recent Progress in Upconversion Photodynamic Therapy

Recent Advances in Near Infrared Upconverting Nanomaterials for Targeted Photodynamic Therapy of Cancer

Riboflavin photoactivation by upconversion nanoparticles for cancer treatment

Near-Infrared Light-Triggered Photodynamic Therapy and Apoptosis Using Upconversion Nanoparticles With Dual Photosensitizers

Upconversion: Red‐Emitting Upconverting Nanoparticles for Photodynamic Therapy in Cancer Cells under Near‐Infrared Excitation (small 11/2013)

In vivo photodynamic therapy using upconversion nanoparticles as remote-controlled nanotransducers

Synergistic Upconversion Photodynamic and Photothermal Therapy under Cold Near-Infrared Excitation.

Near-infrared upconversion photosensitizer enabling photodynamic production and in situ dynamic monitoring of hydroxyl radical in live mice

Near-Infrared Excited Orthogonal Emissive Upconversion Nanoparticles for Imaging-Guided On-Demand Therapy.

Upconversion-based Photodynamic Cancer Therapy

Programmable activation of berbamine and photosensitizers for enhanced photodynamic therapy using emission-switchable upconversion nanoparticles

A new near infrared photosensitizing nanoplatform containing blue-emitting up-conversion nanoparticles and hypocrellin A for photodynamic therapy of cancer cells.

Intelligent Nanotransducer for Deep-Tumor Hypoxia Modulation and Enhanced Dual-Photosensitizer Photodynamic Therapy

Lanthanide-Doped Upconversion Nanoparticles Electrostatically Coupled With Photosensitizers For Near-Infrared-Triggered Photodynamic Therapy

Near-infrared Mediated Orthogonal Bioimaging and Intracellular Tracking of Upconversion Nanophotosensitizers.

Ultrastable Near‐Infrared Conjugated‐Polymer Nanoparticles for Dually Photoactive Tumor Inhibition